162 related articles for article (PubMed ID: 30979818)
1. Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity.
Cheng L; Deng N; Yang N; Zhao X; Lin X
J Immunol; 2019 May; 202(10):3008-3019. PubMed ID: 30979818
[TBL] [Abstract][Full Text] [Related]
2. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
Front Immunol; 2019; 10():1898. PubMed ID: 31474984
[TBL] [Abstract][Full Text] [Related]
3. MALT1 protease function in regulatory T cells induces MYC activity to promote mitochondrial function and cellular expansion.
Rosenbaum M; Schnalzger T; Engleitner T; Weiß C; Mishra R; Mibus C; Mitterer T; Rad R; Ruland J
Eur J Immunol; 2022 Jan; 52(1):85-95. PubMed ID: 34668583
[TBL] [Abstract][Full Text] [Related]
4. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
Baens M; Stirparo R; Lampi Y; Verbeke D; Vandepoel R; Cools J; Marynen P; de Bock CE; Bornschein S
Eur J Immunol; 2018 Oct; 48(10):1728-1738. PubMed ID: 30025160
[TBL] [Abstract][Full Text] [Related]
5. Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated Autoimmunity.
Martin K; Touil R; Kolb Y; Cvijetic G; Murakami K; Israel L; Duraes F; Buffet D; Glück A; Niwa S; Bigaud M; Junt T; Zamurovic N; Smith P; McCoy KD; Ohashi PS; Bornancin F; Calzascia T
J Immunol; 2019 Dec; 203(11):2791-2806. PubMed ID: 31659015
[TBL] [Abstract][Full Text] [Related]
6. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
Front Immunol; 2020; 11():576651. PubMed ID: 33042160
[TBL] [Abstract][Full Text] [Related]
8. TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions.
O'Neill TJ; Gewies A; Seeholzer T; Krappmann D
Front Immunol; 2023; 14():1111398. PubMed ID: 36761777
[TBL] [Abstract][Full Text] [Related]
9. MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.
Kip E; Staal J; Verstrepen L; Tima HG; Terryn S; Romano M; Lemeire K; Suin V; Hamouda A; Kalai M; Beyaert R; Van Gucht S
J Virol; 2018 Apr; 92(8):. PubMed ID: 29367251
[TBL] [Abstract][Full Text] [Related]
10. TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 protease.
O'Neill TJ; Seeholzer T; Gewies A; Gehring T; Giesert F; Hamp I; Graß C; Schmidt H; Kriegsmann K; Tofaute MJ; Demski K; Poth T; Rosenbaum M; Schnalzger T; Ruland J; Göttlicher M; Kriegsmann M; Naumann R; Heissmeyer V; Plettenburg O; Wurst W; Krappmann D
Sci Immunol; 2021 Nov; 6(65):eabh2095. PubMed ID: 34767456
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis.
Gilis E; Gaublomme D; Staal J; Venken K; Dhaenens M; Lambrecht S; Coudenys J; Decruy T; Schryvers N; Driege Y; Dumas E; Demeyer A; De Muynck A; van Hengel J; Van Hoorebeke L; Deforce D; Beyaert R; Elewaut D
Arthritis Rheumatol; 2019 Dec; 71(12):2005-2015. PubMed ID: 31259485
[TBL] [Abstract][Full Text] [Related]
12. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
[TBL] [Abstract][Full Text] [Related]
14. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
[TBL] [Abstract][Full Text] [Related]
15. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.
Gewies A; Gorka O; Bergmann H; Pechloff K; Petermann F; Jeltsch KM; Rudelius M; Kriegsmann M; Weichert W; Horsch M; Beckers J; Wurst W; Heikenwalder M; Korn T; Heissmeyer V; Ruland J
Cell Rep; 2014 Nov; 9(4):1292-305. PubMed ID: 25456129
[TBL] [Abstract][Full Text] [Related]
17. Function and targeting of MALT1 paracaspase in cancer.
O'Neill TJ; Tofaute MJ; Krappmann D
Cancer Treat Rev; 2023 Jun; 117():102568. PubMed ID: 37126937
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.
Martin K; Junker U; Tritto E; Sutter E; Rubic-Schneider T; Morgan H; Niwa S; Li J; Schlapbach A; Walker D; Bigaud M; Beerli C; Littlewood-Evans A; Rudolph B; Laisney M; Ledieu D; Beltz K; Quancard J; Bornancin F; Zamurovic Ribrioux N; Calzascia T
Front Immunol; 2020; 11():745. PubMed ID: 32425939
[TBL] [Abstract][Full Text] [Related]
20. MALT1 is an intrinsic regulator of regulatory T cells.
Brüstle A; Brenner D; Knobbe-Thomsen CB; Cox M; Lang PA; Lang KS; Mak TW
Cell Death Differ; 2017 Jul; 24(7):1214-1223. PubMed ID: 26405015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
